glycine risk_factor_for negative symptoms
Evidence from:
primary |
all sources
Evidence (1 sources)
Glutamatergic transmission in schizophrenia: from basic research to clinical practice.
(2012)
PMID:22297716
cited
Low levels of plasma glycine were associated with higher levels of negative symptoms
confidence: 0.90